Amendment of Statement of Principles concerning non-aneurysmal aortic atherosclerotic disease No. 27 of 2002

Overview

The Veterans' Entitlements Act 1986 was enacted to provide a comprehensive scheme for the payment of pensions, allowances, and other benefits to veterans and their dependants. The Act aims to ensure that those who have served in the Australian Defence Force receive appropriate recognition and support for their service. The legislative instrument F2006B00279, titled "Amendment of Statement of Principles concerning NON-ANEURYSMAL AORTIC ATHEROSCLEROTIC DISEASE," was introduced to address specific medical conditions related to veterans' health, particularly focusing on non-aneurysmal aortic atherosclerotic disease. The Repatriation Medical Authority, under the authority granted by subsection 196B(3) of the Veterans' Entitlements Act 1986, made amendments to Instrument No. 69 of 1998 to refine the definitions and criteria for the recognition and compensation of certain medical conditions. The policy objective of this amendment is to ensure that veterans who suffer from specified cardiovascular conditions receive appropriate medical and financial support, thereby enhancing the effectiveness and fairness of the compensation system.

Scope and Application

The legislative instrument, numbered 27 of 2002, amends the Statement of Principles concerning Non-Aneurysmal Aortic Atherosclerotic Disease, which falls under the Veterans’ Entitlements Act 1986. Specifically, the Repatriation Medical Authority modifies Instrument No. 69 of 1998 by deleting the definition of "diabetes mellitus." This amendment applies to all matters governed by Instrument No. 69 of 1998 and section 120B of the Act, thereby potentially affecting veterans who have previously claimed benefits or who are currently seeking benefits related to non-aneurysmal aortic atherosclerotic disease. The legislative instrument’s amendments are intended to refine the scope of the conditions considered under the Act, thus impacting the criteria and evidence required for veterans to substantiate their claims. The instrument does not explicitly mention any geographic or jurisdictional limitations, suggesting its application extends across the Commonwealth of Australia.

Key Provisions

The primary operative sections of this legislative instrument (Instrument No.27 of 2002) are concerned with the amendment of the Statement of Principles relating to non-aneurysmal aortic atherosclerotic disease. Specifically, section 1 of the instrument revises Instrument No.69 of 1998 by deleting the definition of “diabetes mellitus” in paragraph 8. This change is made under subsection 196B(3) of the Veterans’ Entitlements Act 1986, and it applies to all matters governed by Instrument No.69 of 1998 and section 120B of the Act. In terms of obligations and requirements, the Act imposes specific duties on the Repatriation Medical Authority to amend the existing Statement of Principles concerning non-aneurysmal aortic atherosclerotic disease. This includes the removal of the definition of “diabetes mellitus” from the relevant instrument. By making this amendment, the Authority ensures that the legislative instrument remains up-to-date and relevant to the criteria and conditions under which veterans’ entitlements are assessed. This change likely aims to refine the classification and assessment of conditions related to non-aneurysmal aortic atherosclerotic disease, ensuring that it is not conflated with diabetes mellitus. Regarding the consequences of breaches or non-compliance, the legislative instrument does not explicitly detail offences, penalties, or civil/criminal consequences for breach. However, any failure by the Repatriation Medical Authority to adhere to the requirements stipulated in the Veterans’ Entitlements Act 1986 could potentially lead to legal challenges or administrative actions. Given the nature of the amendment, the primary consequence of non-compliance would be the continued application of an outdated definition, which could result in incorrect assessments or entitlements for affected veterans. This, in turn, could lead to disputes and the need for further legislative or administrative adjustments to correct the oversight. Overall, the instrument is a precise legislative tool designed to update and refine the criteria for assessing veterans’ entitlements related to non-aneurysmal aortic atherosclerotic disease. It underscores the importance of maintaining accurate and relevant definitions within the legislative framework to ensure fair and accurate assessments for veterans.